BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 3086217)

  • 1. Interleukin 2 induces both, growth and maturation of lectin reactive Lyt-2+ but not Lyt-2-precursor cells and regulates the cytolytic potential of effector cells.
    Hochgeschwender U; Diamantstein T; Prester M; Nerz G; Simon MM
    Immunobiology; 1986 Apr; 171(3):274-301. PubMed ID: 3086217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to interferon-gamma inhibit interleukin 2-dependent induction of growth and maturation in lectin/antigen-reactive cytolytic T lymphocyte precursors.
    Simon MM; Hochgeschwender U; Brugger U; Landolfo S
    J Immunol; 1986 Apr; 136(8):2755-62. PubMed ID: 3082972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells.
    Hardt C; Diamantstein T; Wagner H
    Eur J Immunol; 1985 May; 15(5):472-8. PubMed ID: 3158532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulated cytolytic T lymphocyte precursors.
    Erard F; Corthesy P; Nabholz M; Lowenthal JW; Zaech P; Plaetinck G; MacDonald HR
    J Immunol; 1985 Mar; 134(3):1644-52. PubMed ID: 3871453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyt-2+ cells. Requirements for concanavalin A-induced proliferation and interleukin 2 production.
    Kern DE; Lachmann LB; Greenberg PD
    J Immunol; 1987 Nov; 139(9):2880-7. PubMed ID: 2959723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
    Guerne PA; Piguet PF; Vassalli P
    J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes.
    Takai Y; Herrmann SH; Greenstein JL; Spitalny GL; Burakoff SJ
    J Immunol; 1986 Dec; 137(11):3494-500. PubMed ID: 3097123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of T cell subsets from mice bearing the lpr gene.
    Davignon JL; Budd RC; Ceredig R; Piguet PF; MacDonald HR; Cerottini JC; Vassalli P; Izui S
    J Immunol; 1985 Oct; 135(4):2423-8. PubMed ID: 3928747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Lyt-2+ (CD8+) and L3T4+ (CD4+) T cell subsets by anti-receptor antibody.
    Hathcock KS; Segal DM; Hodes RJ
    J Immunol; 1989 Apr; 142(7):2181-6. PubMed ID: 2784455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Lyt-1+ and Lyt-2+ T cell cloned lines: stimulation of proliferation, lymphokine production, and self-destruction.
    Conta BS; Powell MB; Ruddle NH
    J Immunol; 1985 Apr; 134(4):2185-90. PubMed ID: 2579131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three different signals are required for the induction of cytolytic T lymphocytes from resting precursors.
    Kanagawa O
    J Immunol; 1983 Aug; 131(2):606-10. PubMed ID: 6602842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency analysis of class I MHC-reactive Lyt-2+ and class II MHC-reactive L3T4+ IL 2-secreting T lymphocytes.
    Heeg K; Steeg C; Schmitt J; Wagner H
    J Immunol; 1987 Jun; 138(12):4121-7. PubMed ID: 3108383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells.
    Moldwin RL; Havran WL; Nau GJ; Lancki DW; Kim DK; Fitch FW
    J Immunol; 1987 Aug; 139(3):657-64. PubMed ID: 2955046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
    Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
    J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both cloned interleukin 2 and purified interleukin 1 are required for optimal growth of purified L3T4+ and Lyt 2+ lymphocytes initiated by concanavalin A.
    Palacios R; Leu T
    Cell Immunol; 1985 Sep; 94(2):369-82. PubMed ID: 3928171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytolytic T lymphocyte clones that proliferate autonomously to specific alloantigenic stimulation. II. Relationship of the Lyt-2 molecular complex to cytolytic activity, proliferation, and lymphokine secretion.
    Glasebrook AL; Kelso A; MacDonald HR
    J Immunol; 1983 Apr; 130(4):1545-51. PubMed ID: 6187814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential requirements for activation and growth of unprimed cytotoxic and helper T lymphocytes.
    Gullberg M; Pobor G; Bandeira A; Larsson EL; Coutinho A
    Eur J Immunol; 1983 Sep; 13(9):719-25. PubMed ID: 6225649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
    Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
    J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.